DV
Dividend Vision

ATRA — Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. (ATRA)

This is a single-stock equity holding in Atara Biotherapeutics, a biopharmaceutical company, rather than a diversified ETF. The holding generates no dividend distributions and carries no yield profile, making it unsuitable for income-focused investors. This equity position appeals primarily to investors seeking exposure to the biotech sector and potential capital appreciation rather than regular dividend income.

ATRA key facts

Asset type
Stock
Asset class
Equity
Inception date
10/16/2014
Distribution frequency
None
Last close
$8.09
Market cap
$72,892,296
Average volume
66200.0
Beta
0.102
Payout ratio
0.0
Forward P/E
3.6337
EPS
$-1.54